open access

Vol 86, No 1 (2018)
CASE REPORTS
Published online: 2018-02-28
Submitted: 2017-11-14
Accepted: 2018-02-12
Get Citation

Nontuberculous mycobacterial lung disease in a patient with COPD and bronchiectasis, with radiological signs of lung tumor

Dorota Wyrostkiewicz, Monika Szturmowicz, Iwona Bartoszuk, Izabela Siemion-Szcześniak, Lilia Jakubowska, Ewa Augustynowicz-Kopeć, Jan Kuś
DOI: 10.5603/ARM.2018.0005
·
Pubmed: 29490418
·
Adv Respir Med 2018;86(1):17-22.

open access

Vol 86, No 1 (2018)
CASE REPORTS
Published online: 2018-02-28
Submitted: 2017-11-14
Accepted: 2018-02-12

Abstract

Mycobacterial lung disease is caused by nontuberculous mycobacteria (NTM), also known as atypical mycobacteria. NTM are
widely distributed in the environment, particularly in soil and water; they may colonize the airways, gastrointestinal tract and
genitourinary system, without the apparent signs of disease. Nevertheless, in some risk groups such as patients with chronic lung
diseases or with immunodeficiency, mycobacterial lung disease is identified. Recently, increased recognition of mycobacterial
lung disease in chronic obstructive pulmonary disease (COPD) patients has been observed, especially in those treated with high
doses of inhaled corticosteroids.
In the present paper, we describe the patient treated for many years due to COPD and bronchiectasis, with clinical and radiological
picture suggestive of lung tumor, in whom final diagnosis of mycobacterial lung disease caused by Mycobacterium avium was
made.

Abstract

Mycobacterial lung disease is caused by nontuberculous mycobacteria (NTM), also known as atypical mycobacteria. NTM are
widely distributed in the environment, particularly in soil and water; they may colonize the airways, gastrointestinal tract and
genitourinary system, without the apparent signs of disease. Nevertheless, in some risk groups such as patients with chronic lung
diseases or with immunodeficiency, mycobacterial lung disease is identified. Recently, increased recognition of mycobacterial
lung disease in chronic obstructive pulmonary disease (COPD) patients has been observed, especially in those treated with high
doses of inhaled corticosteroids.
In the present paper, we describe the patient treated for many years due to COPD and bronchiectasis, with clinical and radiological
picture suggestive of lung tumor, in whom final diagnosis of mycobacterial lung disease caused by Mycobacterium avium was
made.

Get Citation

Keywords

nontuberculous mycobacterial lung disease, nontuberculous mycobacteria, Mycobacterium avium, bronchiectasis, lung tumor

About this article
Title

Nontuberculous mycobacterial lung disease in a patient with COPD and bronchiectasis, with radiological signs of lung tumor

Journal

Advances in Respiratory Medicine

Issue

Vol 86, No 1 (2018)

Pages

17-22

Published online

2018-02-28

DOI

10.5603/ARM.2018.0005

Pubmed

29490418

Bibliographic record

Adv Respir Med 2018;86(1):17-22.

Keywords

nontuberculous mycobacterial lung disease
nontuberculous mycobacteria
Mycobacterium avium
bronchiectasis
lung tumor

Authors

Dorota Wyrostkiewicz
Monika Szturmowicz
Iwona Bartoszuk
Izabela Siemion-Szcześniak
Lilia Jakubowska
Ewa Augustynowicz-Kopeć
Jan Kuś

References (20)
  1. Griffith DE, Aksamit T, Brown-Elliott BA, et al. ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175(4): 367–416.
  2. Haworth C, Banks J, Capstick T, et al. British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). BMJ Open Respiratory Research. 2017; 4(1): e000242.
  3. Wilińska E. Szturmowicz Mykobakteriozy płuc – obraz kliniczny, diagnostyka i leczenie. Pneumonol Alergol Pol. 2010; 78(2): 138–147.
  4. Hughes WT. Mycobacterial infections in bone marrow transplant recipients. Biol Blood Marrow Transplant. 2000; 6(4): 359–360.
  5. Wallace RJ, Zhang Y, Brown BA, et al. Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med. 1998; 158(4): 1235–1244.
  6. Kubo K, Yamazaki Y, Hachiya T, et al. Mycobacterium avium-intracellulare pulmonary infection in patients without known predisposing lung disease. Lung. 1998; 176(6): 381–391.
  7. Rowińska-Zakrzewska E. Mikobakterioza płuc. Rzadka choroba czy narastający problem epidemiologiczny? Pneumonologia i Alergologia Polska. 2014; 82(6): 486–488.
  8. Śliwiński P, Górecka D, Jassem E, et al. Zalecenia Polskiego Towarzystwa Chorób Płuc dotyczące rozpoznawania i leczenia przewlekłej obturacyjnej choroby płuc. Pneumonologia i Alergologia Polska. 2014; 82(3): 227–263.
  9. Andréjak C, Nielsen R, Thomsen VØ, et al. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013; 68(3): 256–262.
  10. Andréjak C, Thomsen VØ, Johansen IS, et al. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med. 2010; 181(5): 514–521.
  11. Hojo M, Iikura M, Hirano S, et al. Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy. Respirology. 2012; 17(1): 185–190.
  12. Brode SK, Campitelli MA, Kwong JC, et al. The risk of mycobacterial infections associated with inhaled corticosteroid use. Eur Respir J. 2017; 50(3).
  13. Gatheral T, Kumar N, Sansom B, et al. COPD-related bronchiectasis; independent impact on disease course and outcomes. COPD. 2014; 11(6): 605–614.
  14. Char A, Hopkinson NS, Hansell DM, et al. Evidence of mycobacterial disease in COPD patients with lung volume reduction surgery; the importance of histological assessment of specimens: a cohort study. BMC Pulm Med. 2014; 14: 124.
  15. Huang CT, Tsai YJ, Wu HD, et al. Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2012; 16(4): 539–545.
  16. Prevots DR, Loddenkemper R, Sotgiu G, et al. Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs. Eur Respir J. 2017; 49(4).
  17. Korzeniewska-Koseła M. Mykobakteriozy: występowanie, postaci, rozpoznawanie i leczenie. http://www.mp.pl/pulmonologia/artykuly-wytyczne/ pogladowe/show.html?id=116396.
  18. Chu H, Zhao L, Xiao H, et al. Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis. Arch Med Sci. 2014; 10(4): 661–668.
  19. Sato R, Nagai H, Matsui H, et al. Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey. J Infect. 2016; 72(6): 706–712.
  20. Griffith DE, Brown BA, Girard WM, et al. Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus. Clin Infect Dis. 1996; 23(5): 983–989.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl